Modified DSM-5 opioid use disorder criteria for pain patients
Two years ago, I asked, “Doctors diagnosing addiction: Are the blind leading the blind?”
The estimated rates of substance use disorder among clinical patients treated for pain vary greatly, depending on whom one believes. Studies also suffer from a widespread failure to address genetically mediated variability in minimum effective opioid dose between individuals. Thus, I have many times respectfully suggested that the entire body of literature on opioid …












![AI censorship threatens the lifeline of caregiver support [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-2-190x100.jpg)
